Esophageal

Open Clinical Trials

Nivolumab, Ipilimumab, Fluorouracil + Cisplatin

Protocol Number: USOncology 16-165 (www.clinicaltrials.gov)
A Randomized Phase 3 Study of Nivolumab plus Ipilimumab or Nivolumab Combined with Fluorouracil plus Cisplatin versus Fluorouracil Plus Cisplatin in Subjects with Unresectable Advanced, Recurrent or Metastatic Previously Untreated Esophageal Squamous Cell Carincoma – OPEN TO ENROLLMENT